If you're operating a treatment center in 2024, you've probably heard the term EKRA thrown around in compliance conversations. But most behavioral health operators don't fully understand what this law actually prohibits, how it differs from existing anti-kickback regulations, or which of their current business practices could land them in federal prison.
EKRA addiction treatment patient brokering compliance isn't optional. It's criminal law. And since 2018, the Department of Justice has been systematically dismantling the referral and compensation structures that fueled the patient brokering epidemic across the addiction treatment industry.
This article breaks down exactly what EKRA means for your day-to-day operations, which arrangements are now illegal, and how to build compliant referral structures that won't put you in handcuffs.
What EKRA Is and Why It Exists
The Eliminating Kickbacks in Recovery Act (EKRA) became federal law in October 2018 as part of the Substance Use-Disorder Prevention that Promotes Opioid Recovery and Treatment (SUPPORT) Act. Congress designed it specifically to address a problem the existing federal Anti-Kickback Statute couldn't fully reach: patient brokering in the addiction treatment industry.
EKRA makes it a federal crime to pay or receive any remuneration (including kickbacks, bribes, or rebates) to induce a referral to a recovery home, clinical treatment facility, or laboratory. The law applies to all patients, not just those covered by federal healthcare programs. That's the critical difference from previous regulations.
The law emerged directly from the South Florida patient brokering crisis, where body brokers were buying and selling patients like commodities. Marketers received $500 to $5,000 per patient admission. Sober living operators got kickbacks from labs for patient urine samples. Admissions staff earned commissions based on how many beds they filled.
EKRA criminalized all of it. Maximum penalties include 10 years in federal prison and $200,000 in fines per violation.
How EKRA Differs from the Federal Anti-Kickback Statute
Most treatment center operators know about the federal Anti-Kickback Statute (AKS). It's been around since 1972 and prohibits paying for patient referrals in federal healthcare programs like Medicare and Medicaid.
But AKS only applies when federal healthcare dollars are involved. If you're treating privately insured or self-pay patients, traditional AKS enforcement didn't reach you. That gap created the patient brokering economy in states like Florida, California, and Arizona, where high-reimbursing commercial insurance fueled an entire shadow industry of paid referrals.
EKRA closed that gap completely. It applies to every patient referral regardless of payor source: commercial insurance, self-pay, Medicaid, Medicare, cash. If you're operating a recovery residence, clinical treatment facility, or laboratory, EKRA patient brokering addiction treatment law covers your referral arrangements.
You're now subject to both laws simultaneously. That means you need to structure your compensation and referral relationships to comply with both EKRA's safe harbors and AKS's regulatory framework. The overlap creates complexity, but the core principle is simple: you cannot pay for patient referrals, period.
What Patient Brokering Looks Like in Practice
EKRA targets specific arrangements that became standard business practice in parts of the addiction treatment industry. If any of these describe your current operations, you have immediate criminal exposure.
Body Brokers and Paid Referral Networks
The most obvious violation: paying third parties a fee, commission, or bounty for every patient they refer to your facility. This includes marketers, interventionists, discharge planners, or anyone else who gets compensated based on completed admissions.
Real example from DOJ prosecutions: A Florida marketer received $1,000 per patient referred to a network of sober homes and treatment centers. He recruited patients from out-of-state detox facilities, arranged their travel, and collected his fee once they arrived. He's now serving 27 months in federal prison.
Commission-Based Admissions Compensation
Paying your own admissions staff based on how many beds they fill violates EKRA unless structured correctly. If your business development director earns a bonus tied to monthly admission volume, that's prohibited remuneration.
The key distinction: compensation must be for bona fide employment services at fair market value, not calculated based on the volume or value of referrals generated. A salary is compliant. A per-admission commission is not.
Lab Kickback Schemes
One of the most lucrative patient brokering models involved laboratories paying treatment centers or sober homes for patient urine samples. Labs would offer free rent, patient stipends, or direct kickbacks in exchange for exclusive testing arrangements.
EKRA explicitly covers laboratories. If your lab partner is offering anything beyond fair market value compensation for legitimate services, you're both violating federal law. DOJ has secured multiple convictions in this space, with prison sentences exceeding five years.
Sober Living Referral Fees
Many treatment centers developed reciprocal referral relationships with recovery residences: the sober home refers patients to your IOP, you refer your residential step-downs to their housing. If money changes hands based on those referrals, it's illegal under EKRA.
This model was standard practice in South Florida before 2018. It's now a federal crime. When you're building a new treatment program, these referral relationships need to be structured around clinical appropriateness, not financial incentives.
EKRA's Safe Harbors: What's Still Permitted
EKRA includes eight statutory safe harbors that protect specific compensation arrangements. If your relationships fit within these categories, they're compliant. If they don't, they're criminal.
Bona Fide Employment Relationships
You can pay W-2 employees a salary, hourly wage, or benefits for performing legitimate job functions. The compensation must be consistent with fair market value and not determined in a manner that takes into account the volume or value of referrals.
Compliant: A business development director earning $75,000 annually plus performance bonuses based on overall facility census and clinical outcomes.
Non-compliant: The same director earning $50,000 base plus $500 per admission.
Personal Services and Management Contracts
You can pay independent contractors and vendors for legitimate services at fair market value, provided the compensation isn't tied to referral volume. This covers consultants, management companies, and professional service providers.
The contract must specify the services rendered, establish compensation in advance, and document that payment is for actual work performed, not patient referrals generated. Your EHR vendor charging a flat monthly fee is compliant. A marketing consultant earning a percentage of revenue from patients they source is not.
Discounts and Reduced Fees
Offering reduced fees or discounts to patients based on their ability to pay is protected. Scholarships, sliding fee scales, and charity care don't violate EKRA as long as they're not tied to generating referrals from specific sources.
Payment for Advertising and Marketing
You can pay for advertising space, digital marketing services, and promotional materials at fair market rates. What you can't do is structure those payments based on how many referrals the advertising generates.
Compliant: Paying a marketing agency $5,000 per month for SEO, content creation, and paid search management.
Non-compliant: Paying the same agency $200 per lead that converts to an admission.
DOJ Enforcement Trends Through 2021 and Beyond
Since EKRA's passage, the Department of Justice has brought dozens of prosecutions targeting behavioral health fraud. The patterns reveal which practices prosecutors consider highest priority.
South Florida Remains Ground Zero
The Southern District of Florida has led EKRA enforcement, with major cases resulting in prison sentences ranging from 18 months to 10 years. Prosecutors have targeted the entire patient brokering supply chain: body brokers, sober home operators, treatment center owners, and laboratory executives.
Notable case: In 2020, DOJ secured a conviction against a sober home network operator who paid over $1 million in kickbacks to patient brokers. He received 120 months in federal prison and was ordered to forfeit $3.7 million.
Lab Kickback Schemes Draw Aggressive Prosecution
Laboratory fraud cases have resulted in some of the longest sentences under EKRA. The dollar amounts are staggering: one South Florida lab billed insurers over $100 million for medically unnecessary urine drug testing obtained through kickback arrangements.
If your lab relationship includes free services, below-market pricing contingent on volume, or any compensation flowing back to you based on testing volume, expect scrutiny. Operators planning to launch programs in competitive markets need to audit these arrangements before signing contracts.
Pandemic-Era Fraud Increased Federal Attention
The COVID-19 pandemic brought increased federal funding to behavioral health through emergency Medicaid expansions, CARES Act provider relief, and expanded telehealth coverage. It also brought increased DOJ scrutiny of fraud in the sector.
Between 2020 and 2022, federal prosecutors charged over 150 defendants in healthcare fraud schemes involving substance use disorder treatment. Many cases combined EKRA violations with allegations of billing fraud, unnecessary testing, and conspiracy.
State-Level Enforcement Is Also Expanding
While EKRA is federal law, many states have enacted parallel patient brokering statutes with their own enforcement mechanisms. Florida, California, Ohio, and Kentucky have all passed laws criminalizing patient brokering at the state level.
If you're operating in multiple states or considering expansion into markets like Kentucky's Appalachian region, you need to understand both federal EKRA requirements and state-specific patient brokering laws.
Building an EKRA-Compliant Referral Structure
Compliance isn't just about avoiding prosecution. It's about building sustainable referral relationships that generate patient volume without criminal exposure. Here's what that looks like in practice.
Audit Your Current Compensation Arrangements
Start by reviewing every relationship where money flows based on patient referrals or admissions. This includes:
- Business development staff compensation structures
- Marketing agency contracts and performance incentives
- Agreements with sober living operators, interventionists, or discharge planners
- Laboratory contracts and any ancillary services tied to patient volume
- Affiliate relationships with lead generation companies or referral networks
If any arrangement includes payment calculated on a per-patient, per-referral, or volume-based formula, it needs to be restructured or terminated.
Convert Commission Structures to Compliant Compensation
Your admissions and business development team can still be incentivized for performance. The incentives just need to be structured around metrics other than raw admission volume.
Compliant performance metrics include overall facility census, patient retention rates, clinical outcomes, payer mix diversification, and revenue targets that aren't directly tied to individual referrals. Document the methodology in writing and ensure compensation is consistent with fair market value for the role.
Formalize Employment and Contractor Relationships
Every person involved in marketing, admissions, or business development should be either a W-2 employee or an independent contractor with a written agreement that specifies services, compensation, and compliance with EKRA safe harbors.
The agreement should explicitly state that compensation is not based on the volume or value of referrals and that the individual is prohibited from paying or receiving kickbacks for patient referrals. When you're setting up operations in new states, build these compliance frameworks from day one.
Vet Your Laboratory and Ancillary Service Relationships
Your lab partner should charge you fair market rates for testing services based on a fee schedule established in advance. They should not be offering free services, below-market pricing contingent on volume, or any form of remuneration that flows back to your facility based on the number of tests ordered.
If your lab is offering anything that looks like an inducement (free equipment, staff training, patient incentives, rent subsidies), walk away. The risk isn't worth it.
Document Clinical Justification for Referrals
While EKRA focuses on financial arrangements, maintaining documentation that referrals are based on clinical appropriateness rather than financial incentives strengthens your compliance position. Your clinical team should be making placement and referral decisions based on patient needs, level of care criteria, and treatment planning, not business development relationships.
What Eliminating Kickbacks in Recovery Act Compliance Means for Your Operations
Behavioral health anti-kickback statute EKRA fundamentally changed how treatment centers can structure their growth strategies. The referral networks, commission-based sales models, and reciprocal arrangements that drove patient volume in the 2010s are now federal crimes.
But compliance doesn't mean you can't grow. It means you need to build referral relationships around clinical value, reputation, and outcomes rather than financial incentives. The treatment centers thriving in the post-EKRA environment are the ones that invested in clinical quality, patient experience, and legitimate marketing rather than paying for referrals.
If you're operating a facility or planning to open one, EKRA compliance needs to be built into your operational infrastructure from the start. That includes employment agreements, contractor relationships, marketing strategies, and ancillary service contracts. When operators are entering new markets, compliance frameworks should be established before the first patient walks through the door.
Frequently Asked Questions About EKRA and Patient Brokering
Does EKRA apply to outpatient programs like IOP and PHP?
Yes. EKRA applies to any clinical treatment facility, which includes residential programs, partial hospitalization programs (PHP), intensive outpatient programs (IOP), and outpatient counseling services. The law covers the full continuum of addiction treatment services.
Can I pay a referral fee to another treatment center for transferring a patient to my program?
No. Paying another provider for a patient referral violates EKRA regardless of whether the referring facility is a treatment center, hospital, detox, or any other healthcare entity. Referrals between providers must be based on clinical appropriateness, not financial arrangements.
What if I'm only treating self-pay patients with no insurance involvement?
EKRA still applies. Unlike the federal Anti-Kickback Statute, which only covers federally funded healthcare programs, EKRA applies to all patients regardless of payor source. Cash-pay, self-pay, and privately insured patients are all covered under the law.
Are there any exceptions for small facilities or faith-based programs?
No. EKRA applies to all recovery homes, clinical treatment facilities, and laboratories regardless of size, structure, or religious affiliation. The law does not include exemptions based on facility type, patient volume, or organizational mission.
What should I do if I discover my facility has been violating EKRA?
Consult with healthcare legal counsel immediately. Depending on the scope and duration of the violations, you may need to implement corrective action plans, terminate non-compliant arrangements, and potentially make voluntary disclosures to federal authorities. Do not continue operating under arrangements you know violate the law.
How does EKRA affect my relationship with alumni or peer recovery support staff?
You can employ alumni and peer support specialists as W-2 employees at fair market value compensation. What you cannot do is pay them based on how many former patients or peers they refer back to your program. Their compensation must be for legitimate employment services, not referral generation.
Build Compliant Growth Strategies From Day One
EKRA addiction treatment patient brokering compliance isn't just a legal checkbox. It's a fundamental operational requirement that affects how you structure marketing, admissions, referral relationships, and business development across your entire organization.
The treatment centers that succeed long-term are the ones that build compliance into their DNA rather than treating it as an afterthought. That means proper employment agreements, vetted vendor relationships, documented clinical decision-making, and referral networks based on outcomes rather than financial incentives.
At ForwardCare, we help behavioral health operators build compliant operational structures from the ground up. Whether you're launching a new program or auditing existing arrangements for EKRA compliance, our team understands both the regulatory requirements and the practical realities of running a treatment center.
We work with treatment center partners to structure compliant referral networks, develop defensible compensation arrangements, and implement the operational safeguards that reduce criminal exposure while supporting sustainable growth.
If you're ready to build or scale a treatment program with compliance built into the foundation, let's talk. Visit ForwardCare to learn how we support behavioral health operators with the infrastructure, expertise, and operational systems that drive both clinical outcomes and compliant growth.
